dATP Elevation Induces Myocardial Metabolic Remodeling to Support Improved Cardiac Function
Authors:
- Ketaki N MhatreKMKetaki N Mhatre
- Galina FlintGFGalina Flint
- Timothy S. McMillenTMTimothy S. McMillen
- Gerhard WeberGWGerhard Weber
- Majid ShakeriMSMajid Shakeri
- Sonette SteczinaSSSonette Steczina
- Robert WeissRWRobert Weiss
- David J. MarcinekDavid J. Marcinek
- Charles E MurryCMCharles E Murry
- Daniel RafteryDaniel Raftery
Preprint
Abstract
Hallmark features of systolic heart failure are reduced contractility and impaired metabolic flexibility of the myocardium. Cardiomyocytes (CMs) with elevated deoxy ATP (dATP) via overexpression of ribonucleotide reductase (RNR) enzyme robustly improve contractility. However, the effect of dATP elevation on cardiac metabolism is unknown. Here, we developed proteolysis-resistant versions of RNR and demonstrate that elevation of dATP/ATP to ~1% in CMs in a transgenic mouse (TgRRB) resulted in robust improvement of cardiac function. Pharmacological approaches showed that CMs with elevated dATP have greater basal respiratory rates by shifting myosin states to more active forms, independent of its isoform, in relaxed CMs. Targeted metabolomic profiling revealed a significant reprogramming towards oxidative phosphorylation in TgRRB-CMs. Higher cristae density and activity in the mitochondria of TgRRB-CMs improved respiratory capacity. Our results revealed a critical property of dATP to modulate myosin states to enhance contractility and induce metabolic flexibility to support improved function in CMs. Highlights Ubiquitylation-resistant variant RRB in a transgenic mice model (TgRRB) elevates dATP level up to 1% (of the total ATP pool) in the heart and improves function. TgRRB-CMs show greater basal oxygen consumption due to changes in myosin state by dATP. TgRRB-CMs respond to elevated function with a metabolic shift, such that there are higher pools of oxidative metabolites, with elevated OXPHOS, FAO, and energy reserve. Long-term mitochondrial remodeling may occur to accommodate for the higher energy demands of the high functioning TgRRB-CMs.Keywords
All Related Versions
- Published version: Journal of Molecular and Cellular Cardiology, 175, 1.
This publication has 52 references indexed in Scilit:
- Transgenic overexpression of ribonucleotide reductase improves cardiac performanceProceedings of the National Academy of Sciences, 2013
- Impaired Mitochondrial Biogenesis Precedes Heart Failure in Right Ventricular Hypertrophy in Congenital Heart DiseaseCirculation: Heart Failure, 2011
- Importance of the bioenergetic reserve capacity in response to cardiomyocyte stress induced by 4-hydroxynonenalBiochemical Journal, 2009
- Enzymatic property analysis of p53R2 subunit of human ribonucleotide reductaseAdvances in Enzyme Regulation, 2006
- Structurally Dependent Redox Property of Ribonucleotide Reductase Subunit p53R2Cancer Research, 2006
- Characterization of enzymatic properties of human ribonucleotide reductase holoenzyme reconstituted in vitro from hRRM1, hRRM2, and p53R2 subunitsBiochemical and Biophysical Research Communications, 2006
- Cross-Bridge versus Thin Filament Contributions to the Level and Rate of Force Development in Cardiac MuscleBiophysical Journal, 2004
- The Effect of ATP Analogs on Posthydrolytic and Force Development Steps in Skinned Skeletal Muscle FibersBiophysical Journal, 1998
- ATP Analogs and Muscle Contraction: Mechanics and Kinetics of Nucleoside Triphosphate Binding and HydrolysisBiophysical Journal, 1998
- Calcium Regulation of Tension Redevelopment Kinetics with 2-Deoxy-ATP or Low [ATP] in Rabbit Skeletal MuscleBiophysical Journal, 1998